國際實業(000159.SZ)收到西藏大禹第一期股權轉讓款2.15億元
格隆匯2月17日丨國際實業(000159.SZ)公佈,2020年12月29日,經公司第七屆董事會第十九次會議審議通過,同意公司與西藏大禹投資有限公司(以下簡稱“西藏大禹公司”)簽署《股權轉讓合同書》,同意將公司持有的控股子公司北京中昊泰睿投資有限公司100%股權轉讓給西藏大禹投資有限公司,轉讓價4.2億元。
根據合同約定,經公司董事會批准生效後30個工作日內,受讓方向公司支付股權轉讓價款計人民幣2.15億元。截止2021年2月9日,公司已收到受讓方西藏大禹公司支付的第一期股權轉讓款2.15億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.